United States Chronic Disease Management Market Overview

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 13.30% (2024-2032)

The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, and respiratory conditions is acting as a major gaarowth-inducing factor in the chronic disease management market across the United States. According to the latest report by IMARC Group, The United States chronic disease management market size is projected to grow at a CAGR of 13.30% from 2024 to 2032.

United States Chronic Disease Management Industry Trends and Drivers:

As the population ages and lifestyle-related risk factors like obesity, poor diet, and physical inactivity continue to rise, the incidence of chronic diseases escalates. This surge in chronic conditions necessitates ongoing management and monitoring to prevent complications, improve patient outcomes, and reduce healthcare costs. Effective chronic disease management programs, which include regular monitoring, patient education, lifestyle modifications, and medication management, are essential in addressing these health challenges. Consequently, there is a growing demand for healthcare services, technologies, and solutions that can support comprehensive chronic disease management.

Another significant factor driving the chronic disease management market is the advancement in healthcare technology and the increasing adoption of digital health solutions. Innovations such as telemedicine, remote patient monitoring, mobile health applications, and electronic health records (EHRs) have revolutionized the way chronic diseases are managed. These technologies enable continuous monitoring of patients’ health status, facilitate timely interventions, and improve patient engagement and adherence to treatment plans.

For instance, wearable devices and mobile apps can track vital signs, physical activity, and medication adherence, providing valuable data to healthcare providers and empowering patients to take an active role in their health management. Additionally, telemedicine platforms offer convenient access to healthcare services, allowing patients to consult with their healthcare providers without the need for in-person visits. This is particularly beneficial for managing chronic conditions, as it ensures consistent follow-up and support. The integration of artificial intelligence (AI) and data analytics into chronic disease management further enhances predictive modeling and personalized care, optimizing treatment outcomes and reducing the burden on the healthcare system.

Furthermore, supportive government policies and initiatives are propelling the growth of the chronic disease management market. Programs and policies aimed at improving chronic disease care and prevention, such as the Centers for Disease Control and Prevention’s (CDC) National Diabetes Prevention Program and the Medicare Chronic Care Management (CCM) services, provide frameworks and funding to enhance disease management efforts. These initiatives encourage the adoption of evidence-based practices, coordinated care, and the use of health information technology, driving improvements in chronic disease outcomes. Additionally, healthcare reforms and value-based care models emphasize the importance of managing chronic diseases to reduce hospital readmissions and improve overall population health. These policy-driven efforts, combined with increasing awareness and education about chronic disease prevention and management, contribute to the expanding market for chronic disease management solutions in the United States.

United States Chronic Disease Management Industry Segmentation:

The report has segmented the market into the following categories:

Type Insights:

• Solutions
• Services

Disease Type Insights:

• Cardiovascular Diseases
• Diabetes
• Cancer
• Asthma
• Chronic Obstructive Pulmonary Disorders
• Others

Deployment Type Insights:

• On-premises
• Cloud-based
• Web-based

End User Insights:

• Healthcare Providers
• Healthcare Payers
• Others

Regional Insights:

• Northeast
• Midwest
• South
• West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Ask analyst for your customized sample:  https://www.imarcgroup.com/request?type=report&id=20387&flag=F

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145